Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What are the infringers thinking now?

I suspect that if the revenues shown are big enough, the message will get acrossed, and nobody will care all that much about how much each of the Js paid.  I think that if we show just $60M, that might be adequate (even with more licensees thrown in).

Also, I believe that if there are firm multiple payments from the Js forthcoming, this would have to be reflected in the 10Q in some fashion (e.g., accounts receiveable).  After all, such a thing would be considered an asset, and couldn't just be ignored/withheld IMO.

JMHOs,

SGE

 

Share
New Message
Please login to post a reply